BRIEF-Acorda Therapeutics presents data from clinical and preclinical trials of CVT-301
October 13, 2016 at 07:25 AM EDT
* Acorda Therapeutics Inc-presents data from clinical and preclinical trials of CVT-301 for treatment of OFF periods in Parkinson's disease